Injectableskin hair nails$1,200–$3,000 / session

Kybella / Belkyra / ATX-101

Synthetic deoxycholic acid — a naturally occurring bile acid that aids fat digestion — is injected directly into submental (double chin) fat to permanently destroy fat cells. Each treatment session produces permanent elimination of treated fat cells.

How it works

Deoxycholic acid disrupts adipocyte cell membranes via detergent-like phospholipid solubilisation, causing immediate cell lysis. Inflammatory response clears debris; surrounding tissue (skin, muscle, nerves) is spared as deoxycholic acid selectively targets fat cells due to their higher lipid content. The destroyed fat cells cannot regenerate — results are permanent unless significant weight gain occurs.

Reported benefits

  • Permanent submental (double chin) fat reduction
  • Improved jawline definition and neck contour
  • Non-surgical alternative to liposuction for chin fat
  • Off-label: small localised fat deposits (jowls, bra fat, knees)

Regulatory status

European Union· EMA· 2016
Authorized

Approved for: Moderate to severe submental fullness (double chin)

Approved in EU as Belkyra (same active ingredient as Kybella) by EMA in 2016. Marketed by Galderma in Europe.

United Kingdom· MHRA· 2016
Approved

Approved for: Submental fat reduction

Belkyra approved by MHRA for submental fat. Prescription-only medicine. Must be administered by trained medical professional.

United States· FDA· 2015
Approved

Approved for: Submental fullness (double chin) reduction in adults

Kybella (deoxycholic acid) FDA-approved in April 2015 as the first injectable drug approved for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat. Only FDA-approved injectable fat-reduction drug.

Practical details

Frequency: Series of 2–6 sessions, 4–6 weeks apart; results are permanent

Results last: Swelling peaks at days 1–3; resolves in 2–4 weeks; final results visible after 4–6 weeks per session

Contraindications:

  • Active infection at injection site
  • Blood thinning medications
  • Prior surgery in the chin/neck area
  • Dysphagia (difficulty swallowing)
  • Excessive skin laxity (fat removal without concurrent tightening may worsen laxity)
  • Pregnancy or breastfeeding

Always consult a licensed medical professional before undergoing any treatment. This information is educational only and does not constitute medical advice.

Related symptoms